Literature DB >> 12966364

Randomized concentration-controlled trials: motivations, use, and limitations.

Holger Kraiczi1, Theo Jang, Thomas Ludden, Carl C Peck.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12966364     DOI： 10.1016/S0009-9236(03)00169-3

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  9 in total

Review 1.  Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II).

Authors:  Rashmi R Shah
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

2.  Randomized exposure-controlled trials; impact of randomization and analysis strategies.

Authors:  Kristin E Karlsson; Anders Grahnén; Mats O Karlsson; E Niclas Jonsson
Journal:  Br J Clin Pharmacol       Date:  2007-04-10       Impact factor: 4.335

3.  Bisoprolol pharmacokinetics and body composition in patients with chronic heart failure: a longitudinal study.

Authors:  Katja Cvan Trobec; Iztok Grabnar; Mojca Kerec Kos; Tomaz Vovk; Jurij Trontelj; Stefan D Anker; Giuseppe Rosano; Mitja Lainscak
Journal:  Eur J Clin Pharmacol       Date:  2016-03-21       Impact factor: 2.953

4.  Power determination in vitamin D randomised control trials and characterising factors affecting it through a novel simulation-based tool.

Authors:  Jason Wyse; Rebecca Mangan; Lina Zgaga
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

5.  Determination of atomoxetine or escitalopram in human plasma by HPLC: Applications in neuroscience research studies
.

Authors:  Jens Teichert; James B Rowe; Karen D Ersche; Nikolina Skandali; Julia Sacher; Achim Aigner; Ralf Regenthal
Journal:  Int J Clin Pharmacol Ther       Date:  2020-08       Impact factor: 1.366

6.  Considerations for Implementing Precision Therapeutics for Children.

Authors:  Matthew J McLaughlin; Jonathan Wagner; Valentina Shakhnovich; Bruce Carleton; J Steven Leeder
Journal:  Clin Transl Sci       Date:  2019-01-25       Impact factor: 4.689

Review 7.  Optimizing Mycophenolic Acid Exposure in Kidney Transplant Recipients: Time for Target Concentration Intervention.

Authors:  David K Metz; Nick Holford; Joshua Y Kausman; Amanda Walker; Noel Cranswick; Christine E Staatz; Katherine A Barraclough; Francesco Ierino
Journal:  Transplantation       Date:  2019-10       Impact factor: 4.939

Review 8.  TDM is dead. Long live TCI!

Authors:  Nick Holford; Guangda Ma; David Metz
Journal:  Br J Clin Pharmacol       Date:  2020-07-01       Impact factor: 3.716

9.  Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4-5 December 2014).

Authors:  F T Musuamba; E Manolis; N Holford; Sya Cheung; L E Friberg; K Ogungbenro; M Posch; Jwt Yates; S Berry; N Thomas; S Corriol-Rohou; B Bornkamp; F Bretz; A C Hooker; P H Van der Graaf; J F Standing; J Hay; S Cole; V Gigante; K Karlsson; T Dumortier; N Benda; F Serone; S Das; A Brochot; F Ehmann; R Hemmings; I Skottheim Rusten
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.